Retatrutide 50mg (Triple Receptor Agonist)

Welcome to the official VitalisLabs UK product page for Retatrutide 50mg. Representing a major evolution in metabolic research, Retatrutide (LY3437943) is a multi-targeted synthetic peptide engineered to simultaneously activate three distinct receptor pathways: GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and GCGR (Glucagon Receptor).

Buy Retatrutide 50mg UK — High-Purity Research Agonist

When evaluating multi-receptor mechanisms in energy homeostasis and lipid metabolism, reagent purity and sequence integrity are critical. When you buy Retatrutide 50mg UK directly from VitalisLabs, each batch undergoes rigorous third-party testing via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm sequence precision and high stability.

+-----------------------------------------------------------------------+
|                    PRODUCT SPECIFICATION OVERVIEW                     |
|                                                                       |
|  * Product Identifier: VL-RETA-50                                     |
|  * Unit Content: 50mg per vial                                        |
|  * Target Receptors: GLP-1R / GIPR / GCGR (Triple Agonist)             |
|  * Purity Level: >99.0% (HPLC Verified)                               |
|  * Physical Form: Freeze-Dried / Lyophilized White Powder             |
|  * CAS Number: 2381089-83-2                                           |
|                                                                       |
|  [ Download Batch COA Certificate ] ---> Opens PDF                    |
+-----------------------------------------------------------------------+

Mechanisms of Action: Triple Agonism Explained

Unlike mono- or dual-agonist peptides, the Retatrutide peptide UK researchers analyze is designed to interact with three complementary endocrine pathways simultaneously:

1. GIP Receptor Activation: Promotes glucose-dependent insulin secretion and supports adipose tissue lipid clearance.

2. GLP-1 Receptor Activation: Slows gastric emptying, modulates satiety signaling in central nervous system pathways, and regulates postprandial glucose dynamics.

3. Glucagon Receptor (GCGR) Activation: Increases energy expenditure, enhances thermogenesis, and promotes hepatic lipid oxidation—a hallmark mechanism distinguishing triple agonists from earlier metabolic research compounds.

Comparative Analysis: Retatrutide vs. Tirzepatide vs. Semaglutide

Understanding how multi-receptor targeting alters research dynamics is key for comparative trial design:

Technical Specifications: Retatrutide 50mg

Handling, Reconstitution, and Storage Guidelines

1. Lyophilized Storage: Store unopened vials in a freezer at -20°C prior to reconstitution.

2. Reconstitution Solvent: Reconstitute using sterile bacteriostatic water or laboratory-grade saline diluent.

3. Dissolution Method: Direct the solvent stream down the side wall of the glass vial. Allow the lyophilized cake to dissolve naturally without shaking to preserve secondary structural integrity.

4. Post-Reconstitution Storage: Keep reconstituted solutions refrigerated between 2°C and 8°C.

Compliance Disclaimer: All buy research peptides Retatrutide UK products provided by VitalisLabs are strictly intended for laboratory in vitro evaluation, analytical testing, and scientific research. They are not intended for human consumption, clinical usage, or therapeutic administration.